The Society for Maternal-Fetal Medicine released a statement this week addressing the impact of abortion restrictions on medical practice, noting that approximately 41 states currently ban abortion at various stages of pregnancy. The organization’s leadership contends that these legal restrictions fundamentally impede clinicians’ ability to deliver standard evidence-based care to pregnant patients facing serious complications.
The statement comes against a backdrop of documented health impacts from restricted abortion access. Research has found that deaths from ectopic pregnancies nearly doubled between 2020 and 2025, and abortion providers in states without restrictions report that patients are arriving later in pregnancy and in worse health conditions. According to Justin Lappen, chair of the reproductive health committee, maternal-fetal medicine and abortion care are deeply intertwined, as specialists routinely manage cases involving genetic diagnoses, ultrasound findings of fetal anomalies, and complicated maternal medical conditions.
The case of Kate Dineen illustrates these challenges. When she was informed at 33 weeks of pregnancy that her fetus had suffered a catastrophic stroke in utero with poor survival prospects, she sought to end the pregnancy. However, state law restrictions meant she could not access the procedure locally. Despite living in Massachusetts, she was forced to travel to Washington, DC, requiring multiple nights away from home and childcare arrangements for her other child.
The SMFM statement recommends that health systems expand abortion access to the legal maximum permitted in their states and that providers understand and fully utilize existing exceptions in restrictive laws. Lappen emphasized that preparation is essential, as time-sensitive pregnancy emergencies do not allow for extended legal consultation. He noted that complex medical realities exist in gray areas that rigid legal frameworks struggle to accommodate.
Dineen, now an advocate working on reproductive equity, supports the medical society’s guidance while cautioning that exceptions alone do not guarantee access. She noted that despite Massachusetts adding a “grave fetal diagnoses” exception in 2022, patients still faced barriers. However, legislation removing the state’s 24-week ban represents significant progress, she said, allowing providers to make decisions with patients without legal constraints.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI